Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives
Go back to Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives| (NASDAQ: ALLR) | Delayed: 1.39 -0.02 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.41 | 52 Week High | $ | |||
| Open | $1.43 | 52 Week Low | $ | |||
| Day High | $1.44 | P/E | N/A | |||
| Day Low | $1.39 | EPS | $ | |||
| Volume | 5,381 | |||||
| (NASDAQ: ALLR) | Delayed: 1.39 -0.02 (1.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.41 | 52 Week High | $ | |||
| Open | $1.43 | 52 Week Low | $ | |||
| Day High | $1.44 | P/E | N/A | |||
| Day Low | $1.39 | EPS | $ | |||
| Volume | 5,381 | |||||

